# FDA Inspection 1298618 - Octapharma Plasma, Inc. - January 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/5fa15954-3c72-44ce-9d15-dce51e319037
Source feed: FDA_Inspections

> FDA Inspection 1298618 for Octapharma Plasma, Inc. on January 09, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298618
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2026-01-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1315790 - 2026-04-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/7b0bd622-d432-4f56-85d7-af36207fbf65)
- [FDA Inspection 1313722 - 2026-04-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f0fbcfdb-2232-4df9-94a3-5948269e9ba9)
- [FDA Inspection 1255733 - 2024-11-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/3798f79d-193b-470e-a624-30de0b5a7f15)
- [FDA Inspection 1255733 - 2024-11-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/1eec0647-2920-4f18-82cd-53fbb1ea906a)
- [FDA Inspection 1090929 - 2019-04-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8cc0c9a8-f2d2-414f-9ff0-20b301686539)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/0ac5072d-2e4e-4a6e-844e-6a7c763152b8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d